Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Clinical Studies
  • View item
  • Home
  • ICR Divisions
  • Clinical Studies
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The combination of vemurafenib and cobimetinib in advanced melanoma

Thumbnail
View/Open
Accepted version (1016.Kb)
Date
2016-11-01
ICR Author
Larkin, James
Author
Spain, L
Goode, E
McGovern, Y
Joshi, K
Larkin, J
Type
Journal Article
Metadata
Show full item record
URI
https://repository.icr.ac.uk/handle/internal/506
DOI
https://doi.org/10.1080/21678707.2016.1241707
Collections
  • Clinical Studies
Subject
Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
Vemurafenib
cobimetinib
advanced melanoma
BRAF mutation
MAPK pathway
BRAF-MUTATED MELANOMA
RANDOMIZED CONTROLLED-TRIAL
FREE SURVIVAL PFS
METASTATIC MELANOMA
MEK INHIBITION
OPEN-LABEL
POSITIVE MELANOMA
MUTANT MELANOMA
RAF INHIBITION
RESISTANCE
Research team
Melanoma and Kidney Cancer
Language
eng
License start date
2016-11-01
Citation
EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (11), pp. 1105 - 1111 (7)
Publisher
TAYLOR & FRANCIS LTD

Related items

Showing items related by title, author, creator and subject.

  • Thumbnail

    Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma. 

    Bol, KF; van den Bosch, T; Schreibelt, G; Mensink, HW; Keunen, JEE; et al. (2016-10)
  • Thumbnail

    Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma. 

    Pulido, J; Kottke, T; Thompson, J; Galivo, F; Wongthida, P; et al. (2012-03-18)
    Multiple intravenous injections of a cDNA library, derived from human melanoma cell lines and expressed using the highly immunogenic vector vesicular stomatitis virus (VSV), cured mice with established melanoma tumors. ...
  • Thumbnail

    Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy. 

    Ilett, E; Kottke, T; Thompson, J; Rajani, K; Zaidi, S; et al. (2017-01)
    The anti-tumour effects associated with oncolytic virus therapy are mediated significantly through immune-mediated mechanisms, which depend both on the type of virus and the route of delivery. Here, we show that intra-tumoral ...

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.